Haplotype structures of the UGT1A gene complex in a Japanese population

Pharmacogenomics Journal

Volumn 6, Issue 1, 2006, Pages 63-75

  Saeki, M ^a   Saito, Yoshiro ^a,b   Jinno, H ^a   Sai, K ^a   Ozawa, S ^a   Kurose, K ^a   Kaniwa, N ^a   Komamura, K ^c   Kotake, T ^c   Morishita, H ^c   Kamakura, S ^c   Kitakaze, M ^c   Tomoike, H ^c   Shirao, K ^d   Tamura, T ^d   Yamamoto, N ^d   Kunitoh, H ^d   Hamaguchi, T ^d   Yoshida, T ^e   Kubota, K ^f   Ohtsu, A ^f   Muto, M ^f   Minami, H ^f   Saijo, N ^f   Kamatani, N ^g   Sawada, J I ^a,b   more..

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^f NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Haplotype; Linkage disequilibrium; Single nucleotide polymorphism; UGT1A

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCURONOSYLTRANSFERASE; IRINOTECAN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ETHNIC DIFFERENCE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN STRUCTURE; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 31044452504     PISSN: 1470269X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.tpj.6500335     Document Type: Article

References (40)

1. Radominska-Pandya A, Czernik PJ, Little JM. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 1999; 31: 817-899.
2. Tukey RH, Strassburg CP. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol Pharmacol 2001; 59: 405-414.
3. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK et al. Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 2001; 11: 357-368.
4. Metz RP, Ritter JK. Transcriptional activation of the UDP-glucuronosyltransferase 1A7 gene in rat liver by aryl hydrocarbon receptor ligands and oltipraz. J Biol Chem 1998; 273: 5607-5614.
5. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003; 3: 136-158.
6. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, Housman DE. Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: Functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 2000; 10: 629-644.
7. Gagne JF, Montminy V, Belanger P, Journault K, Gaucher G, Guillemette C. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). Mol Pharmacol 2002; 62: 608-617.
8. Huang YH, Galijatovic A, Nguyen N, Geske D, Beaton D, Green J et al. Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 2002; 12: 287-297.
9. Elahi A, Bendaly J, Zheng Z, Muscat JE, Richie Jr JP, Schantz SP et al. Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer 2003; 98: 872-880.
10. Jinno H, Saeki M, Saito Y, Tanaka-Kagawa T, Hanioka N, Sai K et al. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. J Pharmacol Exp Ther 2003; 306: 688-693.
11. Jinno H, Saeki M, Tanaka-Kagawa T, Hanioka N, Saito Y, Ozawa S et al. Functional characterization of wild-type and variant (T2021 and M591) human UDP-glucuronosyltransferase 1A10. Drug Metab Dispos 2003; 31: 528-532.
12. Villeneuve L, Girard H, Fortier LC, Gagne JF, Guillemette C. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs. J Pharmacol Exp Ther 2003; 307: 117-128.
13. Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, Strassburg CP. Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 2004; 39: 970-977.
14. Nagar S, Zalatoris JJ, Blanchard RL. Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 2004; 14: 487-499.
15. Jinno H, Tanaka-Kagawa T, Hanioka N, Saeki M, Ishida S, Nishimura T et al. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D. Drug Metab Dispos 2003; 31: 108-113.
16. Judson R, Stephens JC, Windemuth A. The predictive power of haplotypes in clinical response. Pharmacogenomics 2000; 1: 15-26.
17. Kohle C, Mohrle B, Munzel PA, Schwab M, Wernet D, Badary OA et al. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians. Biochem Pharmacol 2003; 65: 1521-1527.
18. Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, Gold P et al. UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clin Cancer Res 2005; 11: 1226-1236.
19. Sai K, Saeki M, Saito Y, Ozawa S, Katori N, Jinno H et al. UGT1A1 Haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese cancer patients. Clin Pharmacol Ther 2004; 75: 501-515.
20. Saeki M, Saito Y, Jinno H, Sai K, Kaniwa N, Ozawa S et al. Genetic polymorphisms of UGT1A6 in a Japanese population. Drug Metab Pharmacokinet 2005; 20: 85-90.
21. Saeki M, Saito Y, Jinno H, Sai K, Hachisuka A, Kaniwa N et al. Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug Metab Pharmacokinet 2005; 20: 144-151.
22. Iwai M, Maruo Y, Ito M, Yamamoto K, Sato H, Takeuchi Y. Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 2004; 49: 123-128.
23. Kozak M. Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 1997; 16: 2482-2492.
24. Yamanaka H, Nakajima M, Katoh M, Hara Y, Tachibana O, Yamashita J et al. A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 2004; 14: 329-332.
25. Lankisch TO, Vogel A, Eilermann S, Fiebeler A, Krone B, Barut A et al. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene. Mol Pharmacol 2005; 67: 1732-1739.
26. Ando M, Ando Y, Sekido Y, Ando M, Shimokata K, Hasegawa Y. Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients. Jpn J Cancer Res 2002; 93: 591-597.
27. Huang MJ, Yang SS, Lin MS, Huang CS. Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World J Gastroenterol 2005; 11: 797-802.
28. Innocenti F, Liu W, Chen P, Desai AA, Das S, Ratain MJ. Haplotypes of variants in the UDP-glucuronosyltransferase1A9 and 1A1 genes. Pharmacogenet Genomics 2005; 15: 295-301.
29. Ciotti M, Basu N, Brangi M, Owens IS. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus. Biochem Biophys Res Commun 1999; 260: 199-202.
30. Lepine J, Bernard O, Plante M, Tetu B, Pelletier G, Labrie F et al. Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 2004; 89: 5222-5232.
31. Basu NK, Kubota S, Meselhy MR, Ciotti M, Chowdhury B, Hartori M et al. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation. J Biol Chem 2004; 279: 28320-28329.
32. Turgeon D, Chouinard S, Belanger P, Picard S, Labbe JF, Borgeat P et al. Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 2003; 44: 1182-1191.
33. Little JM, Kurkela M, Sonka J, Jantti S, Ketola R, Bratton S et al. Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. J Lipid Res 2004; 45: 1694-1703.
34. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95: 8170-8174.
35. Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 2002; 292: 492-497.
36. Oguri T, Takahashi T, Miyazaki M, Isobe T, Kohno N, Mackenzie PI et al. UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers. Anticancer Res 2004; 24: 2893-2896.
37. Saeki M, Ozawa S, Saito Y, Jinno H, Hamaguchi T, Nokihara H et al. Three novel single nucleotide polymorphisms in UGT1A10. Drug Metab Pharmacokinet 2002; 17: 488-490.
38. Saeki M, Saito Y, Jinno H, Sai K, Komamura K, Ueno K et al. Three novel single nucleotide polymorphisms in UGT1A9. Drug Metab Pharmacokinet 2003; 18: 146-149.
39. Saeki M, Saito Y, Jinno H, Tohkin M, Kurose K, Kaniwa N et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003; 49: 1182-1185.
40. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K et al. Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 2002; 66: 183-193.